reports that research suggests “a little-used asthma drug called amlexanox may potentially be repurposed to treat type 2 diabetes.” Investigators found that using the medication “for 12 weeks was linked to significantly reduced HbA1c in some patients with obesity, type 2 diabetes, and nonalcoholic fatty-liver disease (NAFLD).” The findings were published in Cell Metabolism.
http://www.cell.com/cell-metabolism/fulltext/S1550-4131(17)30348-0
No comments:
Post a Comment